Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2026
Timour Baslan, PhD
Dissecting cancer genetics and biology of the first immune encounter: immune evasion...
Read More
2026
H. Kay Chung, PhD
Rewriting Environmental Signal Interpretation to Overcome T Cell Dysfunction in Solid Tumors
Read More
2026
Sridevi Challa, PhD
Targeting the cytosolic NAD⁺ biosynthesis to prevent ovarian cancer progression
Read More
2026
Pippa Cosper, MD, PhD
Mechanistic dissection of resistance to PSMA-targeted radioligand therapy
Read More
2026
Vivien Maltez, PhD
Converting foe to friend: harnessing cellular plasticity in pancreatic cancer
Read More
2026
Omar Khan, MD, PhD
Pooled, Non-Virally Engineered, and Genetically Enhanced CAR-T Cells for Adult Cancers *The...
Read More
2025
Sita Kugel, PhD
Targeting CDK7 in Patients with Resectable or Borderline Resectable Basal-Like Pancreatic Ductal...
Read More
2025
Erin George, MD
Controlling treatment toxicity in ovarian cancer to prime the patient for tumor...
Read More
2025
Kate Markey, MBBS, PhD
Defining microbial control of immune recovery after cancer treatment
Read More
2025
Giada Bianchi, MD
A novel therapeutic strategy in AL amyloidosis and multiple myeloma: targeting immunoglobulin...
Read More
2025
Alicia Darnell, PhD
Stalling cancer at the ribosome
Read More
2025
Xin Gao, PhD
Mechanisms of mutant ASXL1-driven clonal hematopoiesis and myeloid leukemia
Read More
2025
Prerna Malaney, PhD
Identifying Post-Transcriptional Regulators of Metastasis
Read More
2025
Xin Zhou, PhD
TransTAC Platforms for Targeted Membrane Protein Degradation and Drug Delivery
Read More
2025
Jennifer Rosenbluth, MD, PhD
When Tamoxifen Fails: New Targets for Breast Cancer Prevention
Read More
2025
Rina Plattner, PhD
Targeting ABL1/2 and DDR1 tyrosine kinases for treating NRAS-mutant melanoma
Read More